Interaction of CD44 with different forms of hyaluronic acid. Its role in adhesion and migration of tumor cells

Cell Communication and Adhesion

Volumn 9, Issue 3, 2002, Pages 117-130

  Alaniz, Laura ^a   Cabrera, Paula V ^a   Blanco G , Guillermo ^a   Ernst, Glenda ^a   Rimoldi, Guillermo ^a   Alvarez, Elida ^a   Hajos, Silvia E ^a  

^a UNIVERSIDAD NACIONAL DEL CENTRO DE LA PROVINCIA DE BUENOS AIRES   (Argentina)

Author keywords

CD44; Hyaluronic acid; Lymphoma dissemination; T cell lymphoma lines

Indexed keywords

CD18 ANTIGEN; CD24 ANTIGEN; CD8 ANTIGEN; GLYCOSAMINOGLYCAN; HERMES ANTIGEN; HYALURONIC ACID; HYALURONIDASE; INTERLEUKIN 2 RECEPTOR; LYMPHOCYTE SURFACE MARKER; MONOCLONAL ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; CANCER GROWTH; CELL ADHESION; CELL INVASION; CELL MIGRATION; CLONAL VARIATION; CONTROLLED STUDY; FEMALE; GROWTH RATE; IN VITRO STUDY; IN VIVO STUDY; MALE; METASTASIS; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; T CELL LYMPHOMA; TUMOR CELL LINE;

ANIMALIA; MURINAE;

EID: 0036589677     PISSN: 10615385     EISSN: None     Source Type: Journal    
DOI: 10.1080/15419060214522     Document Type: Review

References (41)

1. Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B (1990). CD44 is the principal cell surface receptor for hyaluronate. Cell 61: 1303-1313.
2. Bartolazzi A, Peach R, Aruffo A, Stamenkovic I (1994). Interaction between CD44 and hyaluronate is directly implicated in the regulation of tumor development. J Exp Med 180: 53-66.
3. Bennett KL, Jackson DG, Simon JC, Tanczos E, Peach R, Modrell B, Stamenkovic I, Plowman G, Aruffo A (1995). CD44 isoforms containing exon v3 are responsible for the presentation of heparin-binding growth factors. J Cell Biol 128: 687-698.
4. Borland G, Ross JA, Guy K (1998). Forms and functions of CD44. Immunology 93: 139-148.
5. Bourguignon LYW, Zhu H, Shao L, Chen Y (2000) CD44 interaction with Tiam 1 promotes Rac1 signaling and hyaluronic acid-mediated breast tumor cell migration. J Biol Chem 275: 1829-1838.
6. Culty M, Nguyen HA, Underhill CB (1992). The hyaluronan receptor (CD44) participates in the uptake and degradation of hyaluronan. J Cell Biol 116: 1055-1062.
7. de Belder AN, Wik KO (1975). Preparation and properties of fluorescein-labeled hyaluronate. Carbohydrate Res 44: 251-257.
8. Ernst GM, Caldas Lopes E, Cabrera P, Alvarez E, Hajos SE (2000). Differential binding of hyaluronic acid in two CD44+ sublines. Relationship with the tumor invasiveness. Medicina 60: 931-939.
9. Esperza J, Villardell C, Calvo J, Juan M, Vives J, Urbano-Marquez A, Yague J, Cid MC (1999). Fibronectin upregulates gelatinase B (MMP-9) and induces coordinated expression of gelatinase A (MMP-2) and its activator MT1-MMP (MMP-14) by human T lymphocyte cell lines. A process repressed through RAS/MAP kinase signaling pathways. Blood 94(8): 2754-2766.
10. Fitzgerald K, Bowie A, Sheehy Skeffington B, O'Neill L (2000). Ras, protein kinase zeta, and I kappa B kinases 1 and 2 are down-stream effectors of CD44 during the activation of NF-kappa B by hyaluronic acid fragments in T24 carcinoma cells. J Immunol 164: 2053-2063.
11. Forrester JV, Balaz EA (1980). Inhibition of phagocytosis by high molecular weight hyaluronate. Immunology 40: 435-446.
12. Fujisaki T, Tanaka Y, Fujii K, Mine S, Saito K, Yamada S, Yamashita U, Irimura T, Eto S (1999). CD44 stimulation induces integrin-mediated adhesion of cancer cell lines to endothelial cells by up-regulation of integrins and c-Met and activation of integrins. Cancer Res 59: 4427-4434.
13. Horton MR, Shapiro S, Bao C, Lowenstwein JC, Noble PW (1999). Induction and regulation of macrophage metalloelastase by hyaluronan fragments in mouse macrophages. J Immunol 162: 4171-4176.
14. Horton M, Olman MA, Bao C, White K, Choi A, Chin B, Noble P, Lowenstein C (2000). Regulation of plasminogen activator inhibitor-1 and urokinase by hyaluronan fragments in mouse macrophages. Am J Physiol Lung Cell Moll Physiol 279: 707-715.
15. Isacke C, Yarwood H (2002). The hyluronan receptor, CD44. IJBCB 34: 718-721.
16. Jalkanen S, Jalkanen M (1992). Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin. J Cell Biol 116: 817-825.
17. Kajita M, Itoh Y, Chiba T, Mori H, Okada A, Kinoh H, Sieki M (2001). Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration. J Cell Biol 153: 893-904.
18. Laurent TC, Fraser JR (1992). Hyaluronan. FASEB J 6: 2397-2404.
19. Lee HG, Cowman MK (1994). An agarose gel electrophoretic method for analysis of hyaluronan molecular weight distribution. Anal Biochem 219: 278-287.
20. Lesley J, He Q, Miyake K, Hamann A, Hyman R, Kincade PW (1992). Requirements for hyaluronic acid binding by CD44: A role for the cytoplasmatic domain and activation by antibody. J Exp Med 175: 257-266.
21. Lesley J, Hyman R, Kincade P (1993). CD44 and its interaction with extracellular matrix. Adv Immunol 54: 271-335.
22. Lugasi H, Hajos S, Murphy J, Strom TB, Nichols J, Peñarroja C, Naor D (1990). Murine spontaneous T-cell leukemia constitutively expressing IL-2 receptor: A model for human T-cell malignancies expressing IL-2 receptor. Int J Cancer 45: 163-167.
23. McKee CM, Lowenstein CJ, Horton MR, Wu J, Chin BY, Choi AM, Noble PW (1997). Hyaluronan fragments induce nitric-oxide synthase in murine macrophages through a nuclear factor κB-dependent mechanism. J Biol Chem 272: 8013-8018.
24. Miyake K, Underhill CB, Lesley J, Kincade PW (1990). Hyaluronate can function as a cell adhesion molecule and CD44 participate in hyaluronate recognition. J Exp Med 172: 69-75.
25. Nandi A, Estess P, Siegelman MH (2000). Hyaluronan anchoring and regulation on the surface of vascular endothelial cell is mediated through the functionally active form of CD44. J Biol Chem 275: 14939-14948.
26. Naor D, Vogt Sionov R, Ish-Shalom D (1997). CD44: Structure, function and association with the malignant process. Adv Cancer Res 71: 241-319.
27. Naujokas MF, Morin M, Anderson MS, Peterson M, Miller J (1993). The chondroitin sulfate form of invariant chain can enhance stimulation of T-cell responses through interaction with CD44. Cell 74: 257-268.
28. Noble P, Lake FR, Henson PM, Riches DW (1993). Hyaluronate activation of CD44 induces insulin-like growth factor-1 expression by a tumor necrosis factor-α dependent mechanism in murine macrophages. J Clin Invest 91: 2368-2377.
29. Noble PW, McKee CM, Cowman M, Shin HS (1996). Hyaluronan fragments activate NF-κB/I-κBα autoregulatory loop in murine macrophages. J Exp Med 183: 2373-2378.
30. Rochman M, Moll J, Herrlich P, Wallach SB, Nedvetzki S, Vogt Sionov R, Golan I, Ish-Shalom D, Naor D (2000). The CD44 receptor of lymphoma cells: Structure-function relationships and mechanism of activation. Cell Adhesion Comm 7:331-347.
31. Rockey D, Chung J, McKee C, Noble P (1998). Stimulation of inducible nitric oxide synthase in rat liver by hyaluronan fragments. Hepatology 27: 86-92.
32. Roden L, Campbell P, Fraser R, Laurent TC, Pertof H, Thompson JN (1989). The Biology of Hyaluronan. (Whelan DEAJ, ed.), pp. 60-78. New York: John Wiley & Sons.
33. Ruggiero RA, Bustuoabad OD, Bonfil RD, Meiss RP, Pasqualini CD (1985). Concomitant immunity in murine tumors of non-detectable immunogenicity. Br J Cancer 51: 37-48.
34. Screaton GR, Bell MV, Jackson DG, Cornelis FB, Gerth U, Bell JL (1992). Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci USA 89: 12160-12164.
35. Stamenkovic I, Aruffo A, Amiot M, Seed B (1991). The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate bearing cells. EMBO J 10: 343-348.
36. Sy MS, Guo YJ, Stamenkovic I (1991). Distinct effects of two CD44 isoforms on tumor growth in vivo. J Exp Med 174: 859-866.
37. Takahashi K, Stamenkovic I, Cutler M, Dasgupta A, Tanabe K (1996). Keratan sulfate modification of CD44 modulates adhesion to hyaluronic. J Biol Chem 271: 9490-9496.
38. Weber GF, Ashkar S, Glimcher MJ, Cantor H (1996). Receptor-ligand interaction between CD44 and osteopontin (Eta-1). Science 271: 509-512.
39. Yu Q, Stamenkovic I (1999). Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion. Genes & Dev 13: 35-48.
40. Zahalka M, Okon E, Naor D (1993). Blocking lymphoma invasiveness with a monoclonal antibody directed against the β-chain of the leukocyte adhesion molecule (CD18). J Immunol 150: 4466-4477.
41. Zahalka M, Okon E, Gosslar U, Holzmann B, Naor D (1995). Lymph node (but not spleen) invasion by murine lymphoma is both CD44- and hyaluronate-dependent. J Immunol 154: 5345-5355.